Clinical Trial Update: Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial for patients with recurrent or refractory non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: WITHDRAWN